JPRN-UMIN000002333已完成未知
Additional effects of pioglitazone on type 2 diabetes who were inappropriately controled with - ACTION-J
Department of Medicine, Metabolism and Endocrinology Juntendo University School of Medicine0 个研究点目标入组 100 人开始时间: 2009年8月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.the patients who had CVD or appoplexy within 6 months 2. the patients who have had hear failure (NYHA >III) 3. severe hepatic or renal failure 4. the patients who have had diabetic ketoacidosis 5. pregnant women 6. the pateints who has history of severe adverse effects with pioglitazone
研究者
相似试验
进行中（未招募）
不适用
Effects of Pioglitazone in Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease at High Risk for Cardiovascular ComplicationsEUCTR2004-004226-28-DETakeda Pharma GmbH
已完成
4 期
Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart DiseaseType 2 Diabetes MellitusCardiovascular DiseaseNCT00479986IKFE Institute for Clinical Research and Development92
已完成
4 期
Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell FunctionHealthyImpaired Glucose ToleranceType 2 DiabetesNCT00845182The University of Texas Health Science Center at San Antonio43
已完成
不适用
Effect of Pioglitazone on kidney transplantation in diabetic patientsCondition 1: Diabetis. Condition 2: Transplanted kidney.Insulin-dependent diabetes mellitustransplanted kidneyIRCT2012121811807N1Deputy of Research and Technology, Shahid beheshti pharmacy faculty60
招募中
不适用
The effect of pioglitazone on reducing methamphetamine dependence.Methamphetamine dependent patients.IRCT20190427043389N1Zanjan University of Medical Sciences100